Profile of past and current clinical trials involving endothelin receptor antagonists: the novel "-sentan" class of drug.

MLA

Battistini, Bruno, et al. “Profile of Past and Current Clinical Trials Involving Endothelin Receptor Antagonists: The Novel ‘-Sentan’ Class of Drug.” Experimental Biology and Medicine (Maywood, N.J.), vol. 231, no. 6, June 2006, pp. 653–95. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=16740981&authtype=sso&custid=ns315887.

APA

Battistini, B., Berthiaume, N., Kelland, N. F., Webb, D. J., & Kohan, D. E. (2006). Profile of past and current clinical trials involving endothelin receptor antagonists: the novel “-sentan” class of drug. Experimental Biology and Medicine (Maywood, N.J.), 231(6), 653–695.

Chicago

Battistini, Bruno, Nathalie Berthiaume, Nicholas F Kelland, David J Webb, and Donald E Kohan. 2006. “Profile of Past and Current Clinical Trials Involving Endothelin Receptor Antagonists: The Novel ‘-Sentan’ Class of Drug.” Experimental Biology and Medicine (Maywood, N.J.) 231 (6): 653–95. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=16740981&authtype=sso&custid=ns315887.